Price $19.18 |
Market Cap
790.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.79
|
P/S
2.86
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-9.5K
|
FCF
-0.3
|
|
Op. Margin
-7.10%
|
Net Margin
-7.80%
|
ROE
-7.40%
|
ROI
-4.20%
|
|
ROA
-5.80%
|
EPS Growth
23.70%
|
Current Ratio
5.2
|
Debt/Equity
7.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Surgalign Holdings Inc (SRGA) | $0.85 | - | - | 100.6M | Strong Buy |
| Mediwound Ltd (MDWD) | $2.89 | - | - | 67.3M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.66 | - | - | 68.5M | Strong Buy |
| Endo International PLC (ENDP) | $3.27 | - | - | 923M | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.21 | - | - | 6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
